<DOC>
	<DOCNO>NCT01402245</DOCNO>
	<brief_summary>Pneumococcal polysaccharide vaccine confer protection noninvasive pneumonia . The study aim compare lymphocyte home pneumonia receive Pnc polysaccharide vaccine ( PPV ) Pnc conjugate vaccine ( PCV )</brief_summary>
	<brief_title>Targeting Immune Response After Pneumococcal Vaccination</brief_title>
	<detailed_description>Pneumococcal polysaccharide vaccine confer protection noninvasive pneumonia . The study compare home profile Pnc-specific plasmablast 15 patient pneumonia 15 volunteer receive Pnc polysaccharide vaccine ( PPV ) 12 volunteer receive Pnc conjugate vaccine ( PCV )</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Pneumococcal</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Males female ≥ 18 &lt; 65 year age . General good health . Written informed consent . No previous vaccination Pnc No previous history Pnc pneumonia In pneumonia : Diagnosis Pnc pneumonia within week &lt; 18 year , ≥65 age . In vaccinee : Acute disease time enrollment . Pregnancy lactation . Known immunodeficiency immune suppressive treatment . Any chronic illness might interfere immune response Alcohol drug abuse Any clinically significant history know suspected anaphylaxis hypersensitivity ( base investigator 's judgement ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>pneumonia</keyword>
	<keyword>pneumococcal polysaccharide vaccine</keyword>
	<keyword>pneumococcal conjugate vaccine</keyword>
</DOC>